Tocilizumab may slow radiographic progression in patients with systemic or polyarticular-course juvenile idiopathic arthritis: post hoc radiographic analysis from two randomized controlled trials

被引:0
|
作者
Clara Malattia
Nicolino Ruperto
Silvia Pederzoli
Elena Palmisani
Angela Pistorio
Carine Wouters
Pavla Dolezalova
Berit Flato
Stella Garay
Gabriella Giancane
Chris Wells
Wendy Douglass
Hermine I. Brunner
Fabrizio De Benedetti
Angelo Ravelli
机构
[1] Università degli Studi di Genova,IRCCS Istituto Giannina Gaslini
[2] Clinica Pediatrica e Reumatologia,IRCCS Istituto Giannina Gaslini
[3] PRINTO,General University Hospital and First Faculty of Medicine
[4] Servizio di Epidemiologia e Biostatistica,undefined
[5] University Hospital Gasthuisberg,undefined
[6] Charles University,undefined
[7] Oslo University Hospital and University of Oslo,undefined
[8] Hospital Sor Maria Ludovica,undefined
[9] Roche Products Ltd.,undefined
[10] Cincinnati Children’s Hospital Medical Center,undefined
[11] IRCCS Ospedale Pediatrico Bambino Gesú,undefined
[12] Sechenov First Moscow State Medical University,undefined
关键词
Biologicals; Disease-modifying antirheumatic drugs (DMARDs); Tocilizumab; Systemic juvenile idiopathic arthritis; Polyarticular-course juvenile idiopathic arthritis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Functional Ability and Health-Related Quality of Life in Randomized Controlled Trials of Tocilizumab in Patients With Juvenile Idiopathic Arthritis
    Brunner, Hermine I.
    Chen, Chen
    Bovis, Francesca
    De Benedetti, Fabrizio
    Espada, Graciela
    Joos, Rik
    Akikusa, Jonathan
    Chaitow, Jeffrey
    Boteanu, Alina Lucica
    Kimura, Yukiko
    Rietschel, Christoph
    Siri, Daniel
    Smolewska, Elzbieta
    Schmeling, Heinrike
    Brown, Diane E.
    Martini, Alberto
    Lovell, Daniel J.
    Huang, Bin
    Ruperto, Nicolino
    ARTHRITIS CARE & RESEARCH, 2021, 73 (09) : 1264 - 1274
  • [32] Treatment with leflunomide slows radiographic progression of rheumatoid arthritis - Results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis
    Sharp, JT
    Strand, V
    Leung, H
    Hurley, F
    Loew-Friedrich, I
    ARTHRITIS AND RHEUMATISM, 2000, 43 (03): : 495 - 505
  • [33] PReS-FINAL-2134: Assessment of radiographic progression in patients (pts) with systemic juvenile idiopathic arthritis (sjia) treated with tocilizumab (TCZ): 2-year results from the tender trial
    C Malattia
    N Ruperto
    E Palmisani
    S Pederzoli
    A Pistorio
    HI Brunner
    R Cuttica
    I Calvo
    SM Garay
    D Eleftheriou
    C Wouters
    J Wang
    C Devlin
    D Lovell
    A Martini
    F De Benedetti
    A Ravelli
    Pediatric Rheumatology, 11 (Suppl 2)
  • [34] Effect of Biologics on Radiographic Progression of Peripheral Joints in Patients with Psoriatic Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Wu, Dongze
    Wong, Priscilla
    Griffith, James F.
    Yue, Jiang
    Tam, Lai-Shan
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [35] EFFECT OF TNF ANTAGONISTS ON RADIOGRAPHIC PROGRESSION IN PSORIATIC ARTHRITIS: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Goulabchand, R.
    Mouterde, G.
    Barnetche, T.
    Morel, J.
    Combe, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 570 - 570
  • [36] Effect of TNF Antagonists On Radiographic Progression in Psoriatic Arthritis: Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Goulabchand, Radjiv
    Mouterde, Gael
    Lukas, Cedric
    Barnetche, Thomas
    Morel, Jacques
    Combe, Bernard
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S246 - S247
  • [37] Comparison of the efficacy and safety of biological agents in patients with systemic juvenile idiopathic arthritis: A Bayesian network meta-analysis of randomized controlled trials
    Song, Gwan Gyu
    Lee, Young Ho
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2021, 59 (03) : 239 - 246
  • [38] Long-term Efficacy and Safety of Subcutaneous Tocilizumab in Patients with Polyarticular or Systemic Juvenile Idiopathic Arthritis - an Extension Study of 2 Phase 1b Clinical Trials
    Brunner, Hermine
    Ramanan, Athimalaipet
    Horneff, Gerd
    Minden, Kirsten
    Calvo Penades, Inmaculada
    Zucchetto, Mauro
    Brockwell, Laura
    Gordon, Oliver
    De Benedetti, Fabrizio
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 4390 - 4393
  • [39] Long-term, interventional, open-label extension study evaluating the safety of tocilizumab treatment in patients with polyarticular-course juvenile idiopathic arthritis from Poland and Russia who completed the global, international CHERISH trial
    Opoka-Winiarska, Violetta
    Zuber, Zbigniew
    Alexeeva, Ekaterina
    Chasnyk, Vyacheslav
    Nikishina, Irina
    Debowska, Grazyna
    Smolewska, Elzbieta
    CLINICAL RHEUMATOLOGY, 2018, 37 (07) : 1807 - 1816
  • [40] Long-term, interventional, open-label extension study evaluating the safety of tocilizumab treatment in patients with polyarticular-course juvenile idiopathic arthritis from Poland and Russia who completed the global, international CHERISH trial
    Violetta Opoka-Winiarska
    Zbigniew Żuber
    Ekaterina Alexeeva
    Vyacheslav Chasnyk
    Irina Nikishina
    Grażyna Dębowska
    Elżbieta Smolewska
    Clinical Rheumatology, 2018, 37 : 1807 - 1816